.avif)
Octapharma Email Format
Pharmaceutical Manufacturing
・
10,001-25,000 employees
・
Lachen, Switzerland
Octapharma is a family-owned global pharmaceutical company that develops and manufactures human protein-based medicines for critical care, haematology, and immunotherapy across 120 countries.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@octapharma.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1983
Headquarters
Lachen, Switzerland
Revenue
$2.5B-$5B
FUNDING Stage
Family-Owned
Website
Key Executives
Wolfgang Marguerre (Chairman and CEO, Octapharma Group), Roger Machler (Chief Financial Officer), Olivier Clairotte (Chief Production Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Octapharma?
Octapharma uses the first.last format on octapharma.com, so Jane Smith would be jane.smith@octapharma.com.
What are the three therapeutic areas that Octapharma focuses on?
Octapharma develops and manufactures plasma-derived and recombinant therapies across three therapeutic areas: haematology, immunotherapy, and critical care. Its products treat patients in more than 118 countries worldwide.
Which haematology products does Octapharma sell for treating Hemophilia A?
Octapharma markets NUWIQ, a recombinant factor VIII therapy, and wilate, a human factor VIII and von Willebrand factor complex, both used in the treatment of Hemophilia A and related bleeding disorders.
How can I find and verify the right Octapharma contact for my outreach?
Since Octapharma uses the first.last@octapharma.com format, you can build contact emails directly from a name. Tools like Clay can help you verify those addresses and enrich prospect records with role and location data before reaching out.
Where are Octapharma's manufacturing facilities located?
Octapharma operates six manufacturing facilities across Austria, France, Germany, Mexico, and Sweden, along with seven R&D sites, supporting its global supply of plasma-derived and recombinant protein therapies.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating